1. Home
  2. RDHL vs AMBO Comparison

RDHL vs AMBO Comparison

Compare RDHL & AMBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • AMBO
  • Stock Information
  • Founded
  • RDHL 2009
  • AMBO 2000
  • Country
  • RDHL Israel
  • AMBO United States
  • Employees
  • RDHL N/A
  • AMBO N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • AMBO Other Consumer Services
  • Sector
  • RDHL Health Care
  • AMBO Real Estate
  • Exchange
  • RDHL Nasdaq
  • AMBO Nasdaq
  • Market Cap
  • RDHL 8.2M
  • AMBO 7.2M
  • IPO Year
  • RDHL N/A
  • AMBO 2010
  • Fundamental
  • Price
  • RDHL $5.85
  • AMBO $2.60
  • Analyst Decision
  • RDHL
  • AMBO
  • Analyst Count
  • RDHL 0
  • AMBO 0
  • Target Price
  • RDHL N/A
  • AMBO N/A
  • AVG Volume (30 Days)
  • RDHL 11.1K
  • AMBO 127.9K
  • Earning Date
  • RDHL 08-29-2024
  • AMBO 12-30-2024
  • Dividend Yield
  • RDHL N/A
  • AMBO N/A
  • EPS Growth
  • RDHL N/A
  • AMBO N/A
  • EPS
  • RDHL N/A
  • AMBO N/A
  • Revenue
  • RDHL $3,707,000.00
  • AMBO $7,839,000.00
  • Revenue This Year
  • RDHL $224.90
  • AMBO N/A
  • Revenue Next Year
  • RDHL $82.69
  • AMBO N/A
  • P/E Ratio
  • RDHL N/A
  • AMBO N/A
  • Revenue Growth
  • RDHL N/A
  • AMBO N/A
  • 52 Week Low
  • RDHL $5.41
  • AMBO $1.00
  • 52 Week High
  • RDHL $20.28
  • AMBO $6.30
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 40.41
  • AMBO 53.97
  • Support Level
  • RDHL $5.80
  • AMBO $2.21
  • Resistance Level
  • RDHL $6.26
  • AMBO $2.85
  • Average True Range (ATR)
  • RDHL 0.31
  • AMBO 0.31
  • MACD
  • RDHL 0.01
  • AMBO 0.03
  • Stochastic Oscillator
  • RDHL 19.33
  • AMBO 70.45

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.

About AMBO Ambow Education Holding Ltd.

Ambow Education Holding Ltd is a provider of educational and career enhancement services in China. It operates through CP&CE Programs. The CP&CE Programs include tutoring services and career enhancement services. Geographically all the operations function in the United States and Foreign countries.

Share on Social Networks: